Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02212314 · ClinicalTrials.gov registry record · NA
Response Inhibition Training for Children With Williams Syndrome
A NA study, sponsored by University of Wisconsin, Milwaukee.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT02212314: Completed NA study, sponsored by University of Wisconsin, Milwaukee.
NCT02212314 is a NA study that has completed, run by University of Wisconsin, Milwaukee. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02212314, a NA study, has completed, sponsored by University of Wisconsin, Milwaukee.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The investigators will conduct a pilot study investigating the effectiveness of a computerized response inhibition training program at reducing the response inhibition difficulties often seen in children with Williams syndrome ages 10-17. The investigators hypothesize that after completing the training program, children with Williams syndrome will show improvement on computerized measures of response inhibition and on parent measures of impulsivity.
Primary Outcome
Three measures of response inhibition that were administered to children at pre-test will be administered after the 5-7-week training and again at a 3-month follow-up. Measures include computer-administered Motor Stroop task, Stop Signal task, and Go/No-Go Task.
Interventions
- BEHAVIORAL Response Inhibition Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-05 |
| Phase | NA |
What the finished NCT02212314 record still lists
NCT02212314 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Response Inhibition Training is the first listed.
NCT02212314 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02212314 about?
NCT02212314 is a clinical study titled "Response Inhibition Training for Children With Williams Syndrome". The investigators will conduct a pilot study investigating the effectiveness of a computerized response inhibition training program at reducing the response inhibition difficulties often seen in children with Williams syndrome ages 10-17. The investigators hypothesize that after completing the train...
What is the current status of trial NCT02212314?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2014-05. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02212314?
The interventions under investigation include: Response Inhibition Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02212314?
This trial is sponsored by University of Wisconsin, Milwaukee, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02212314's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia